FDA approves new drug Leqembi to treat early Alzheimer’s disease
Jan 09, 2023
The newly approved drug Leqembi (lecanemab) may slow progression of cognitive decline due to Alzheimer’s disease, trial data show. CMS says it may rethink Medicare coverage of drugs in Leqembi’s...
Drugmakers ask FDA to approve another Alzheimer’s drug, similar to Aduhelm
Sep 29, 2021
Drugmakers Eisai and Biogen are putting the Food and Drug Administration to the test with a request to approve a second Alzheimer’s drug that works like aducanumab (Aduhelm), the new, yet controversial,...
Higher dose of Alzheimer’s drug approved despite FDA warnings, report shows
Mar 26, 2012
Makers of the Alzheimer’s drug Aricept released a higher dosage version of the medication despite concerns about side effects and reduced efficacy, a study reports.